Molecular detection of dopamine decarboxylase expression by means of reverse transcriptase and polymerase chain reaction in bone marrow and peripheral blood: Utility as a tumor marker for neuroblastoma

Diagnostic Molecular Pathology

Volumn 13, Issue 3, 2004, Pages 135-143

  Bozzi, Fabio ^a   Luksch, Roberto ^a   Collini, Paola ^a   Gambirasio, Felicita ^a   Barzanò, Elena ^a   Polastri, Daniela ^a   Podda, Marta ^a   Brando, Bruno ^b   Fossati Bellani, Franca ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

CD56; Dopamine decarboxylase; Neuroblastoma; RT PCR; Tyrosine hydroxylase

Indexed keywords

CARBOXYLYASE; DOPAMINE DECARBOXYLASE; MESSENGER RNA; TUMOR MARKER; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD; BLOOD SAMPLING; BONE MARROW; CANCER STAGING; CATECHOLAMINE SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANTIGENS, CD56; BONE MARROW; CELL LINE, TUMOR; CHILD, PRESCHOOL; DOPA DECARBOXYLASE; FLOW CYTOMETRY; HUMANS; INFANT; NEUROBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; TYROSINE 3-MONOOXYGENASE;

EID: 4344618577     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pdm.0000128699.14504.06     Document Type: Article

References (27)

1. Moss JT, Reynolds CP, Sather HN, et al. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. New Engl J Med. 1991;324:219-226.
2. Seeger RC, Reynolds CP, Gallego R, et al. Quantitative tumour cell content of bone marrow and blood as a predictor of outcome in stage 4 neuroblastoma: a Children's Cancer Group Study. J Clin Oncol. 2000;15: 4067-4076.
3. Faulkner LB, Garaventa A, Paoli A, et al. In vivo cytoreduction studies and cell sorting-enhanced tumour-cell detection in high-risk neuroblastoma patients: implications for leukapheresis strategies. J Clin Oncol. 2000;18:3829-3836.
4. Cheung IY, Cheung NK. Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumour marker for neuroblastoma. Clin Cancer Res. 1997;3:821-826.
5. Lo Piccolo MS, Cheung NK, Cheung IY. GD2 synthase: a new molecular marker for detecting neuroblastoma. Cancer. 2001;92:924-931.
6. Mattano LA Jr, Moss JT, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res. 1992;5:4701-4705.
7. Pagani A, Macri L, Faulkner LB, et al. Detection procedures for neuroblastoma cells metastatic to blood and bone marrow: blinded comparison of chromogranin A heminested reverse transcription polymerase chain reaction to tyrosine hydroxylase nested reverse transcription polymerase chain reaction and to anti-GD2 immunocytology. Diagn Mol Pathol. 2002;11:98-106.
8. Naito H, Kuzumaki N, Uchino J, et al. Ishikawa Y Matsumoto S. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer. 1991; 27:762-765.
9. Gilbert J, Haber M, Bordow SB, et al. Use of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round cell malignancies. Am J Pathol. 1999;155:17-21.
10. Tuchman M, Ramnaraine MLR, Woods WG, et al. Three years experience with random urinary homovanillic and vanillymandelic acid levels in the diagnosis of neuroblastoma. Pediatrics. 1987;79:203-205.
11. Warzynski MJ, Graham DM, Axtell RA, Higgins JV, Hammers YA. Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients. Cytometry. 2002;50:298-304.
12. Brodeur GM, Pritchard J, Berthold F, et al. Revision of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:466-477.
13. Keilholz U. Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group. Eur J Cancer. 1998;34:750-753.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
15. Nagatsu T, Hori TA, Takahashi EI, et al. Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic 1-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry (Mosc). 1992;162:2229-2238.
16. Lode HN, Handgretinger U, Schuermann Seitz G, et al. Detection of neuroblastoma cells in CD 34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry. Eur J Cancer. 1997;33:2024-2030.
17. Lode HN, Bruchelt G, Seitz G, et al. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression. Eur J Cancer. 1995; 31A:586-590.
18. Fukuda M, Miyajima Y, Miyashita Y, et al. Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study. J Pediatr. Hematol Oncol. 2001;23:10-13.
19. Horibe K, Fukuda M, Miyajima Y, et al. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma. Med Pediatr Oncol. 2001;36:203-204.
20. Burchill SA, Bradbury FM, Selby P, et al. Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Eur J Cancer. 1995; 31 A:553-556.
21. Miyajima Y, Horibe K, Fukuda M, et al. Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage 4 neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer. 1996;77:1214-1219.
22. Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med. 1994;331:294-299.
23. Burchill SA, Wheeldon J, Cullinane C, et al. EWS-FLII fusion transcripts identified in patients with typical neuroblastoma. Eur J Cancer. 1997;33: 239-243.
24. Burchill SA, Lewis IJ, Abrams KR, et al. Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J Clin Oncol. 2001;19:1795-1801.
25. Pession A, Libri V, Sartin R, et al. Real-time RT-PCR of tyrosine hydroxylase to detect bone marrow involvement in advanced neuroblastoma. Oncol Rep. 2003;10:357-362.
26. Lambooy LHJ, Gidding CEM, van den Heuvel LP, et al. Real-time analysis of tyrosine hydroxylase gene expression: A sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma. Clin Cancer Res. 2003;9:812-819.
27. Mora J, Gerald WL, Qin JNK, et al. Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma. Cancer. 2002;94:2756-2765.